All In MedTech

Device Trial Radar · NCT06850363

ExaStim Upper Limb Home Use Clinical Validation Study

Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

Mar 17, 2025

Primary completion

Mar 11, 2026

Study completion Mar 11, 2026

Sponsor

Lead sponsor
Niche Biomedical, Inc. dba ANEUVONot on our public-company list
Sponsor type
Industry
First posted
Feb 27, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseline evaluation and 1-week training period (Week 0), a 4-week stimulation period (Weeks 1-4), and a follow-up visit (Week 5), for a total expected duration of participation for each subject of six weeks.

Conditions

  • Cervical Spinal Cord Injury

Interventions

  • ExaStim Stimulation SystemDevice

    Transcutaneous Spinal Cord Stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Incidence of device related adverse eventsTime frame: Occurrence over 6-weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Craig Rehabilitation Hospital

    Denver, Colorado

  • TryAbility Neurorecovery Center

    Downer Grove, Illinois

  • Internation Center for Spinal Cord Injury at the Kennedy Krieger Institute

    Baltimore, Maryland

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.